Edinburgh Research Explorer
Profile photo

Education/Academic qualification

Doctor of Philosophy (PhD), University of Leeds

Professional Qualifications

Member of the Royal College of Physicians of Edinburgh, MRCP

Research Interests

Dr Hall's research interests reside at the interface between Medical Oncology, Health Economics and Clinical Research. They include:

  • Economic evaluation of new interventions for cancer
  • Bayesian decision analysis for efficient research design
  • Economic evaluation of biomarkers and personalised medicine strategies
  • The use of routine NHS data through clinical informatics to measure the costs of care
  • Methods for the measurement of the financial burden of cancer on patients and carers
  • Outcomes measurement in elderly cancer patients

His aspiration is to improve clinical outcomes of research to provide robust evidence for the real-world evaluation of new interventions for cancer

Biography

A Medical Oncologist with a research interest in and Health Economics, he holds a position as a Senior Clinical Lecturer in Cancer Informatics at the Edinburgh Cancer Research Centre, University of Edinburgh. He is also Visiting Associate Professor of Health Economics with the Academic Unit of Health Economics at the University of Leeds. 

The focus of his research is on improved methods for efficient research design, cost-effectiveness analysis and the measurement of clinical and socioeconomic outcomes using data obtained from research and routinely collected within the NHS. 

He is Chief-Investigator, clinical co-investigator or lead Health Economist on a number of clinical trials and methods projects. He leads the Health Economics Group within the University of Edinburgh Clinical Trials Unit. He is a Visiting Associate Professor of Health Economics at the Academic Unit of Health Economics, University of Leeds where he completed a PhD in health economic modelling. He is a NICE Appraisal Committee member and advises the Innovative Healthcare Delivery Programme Scotland at the Farr Institute. He treats patients with breast cancer at the Edinburgh Cancer Centre.

 

Highlighted research outputs

  1. Real‑world treatment in patients with HER2+ metastatic breast cancer

    Research output: Contribution to journalArticle

  2. Real-world data for efficient health technology assessment

    Research output: Contribution to journalEditorial

  3. Accurate Measurement of Financial Toxicity Is a Prerequisite to Finding a Remedy

    Research output: Contribution to journalEditorial

  4. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer

    Research output: Contribution to journalArticle

  5. Balancing the Economics and Ethics of Personalised Oncology

    Research output: Contribution to journalArticle

View all (105) »

ID: 18885232